Likewise, Megan et al., via CyTOF and RNA-seq analyses, uncovered higher CD8+ T cell populations in murine bladder cancer upon DDR2 depletion and anti-PD-1 treatment, implying that DDR2 inhibition might fuel tumor response to ICIs (29). Here, DDR2 is linked to urinary bladder carcinoma.